findings

Grizzly Research Releases Coverage Report on GigaCloud (NASDAQ:GCT)

New York, May 22, 2024 – Grizzly Research has released a comprehensive coverage report on GigaCloud Technology Inc. (NASDAQ: GCT). The report provides an in-depth analysis of GigaCloud’s business operations, highlighting several areas of concern regarding the company’s financial reporting and operational practices. A copy of the report can be found here: Grizzly GCT Report Key Findings: 1.Discrepancies in Gross Merchandise Value (GMV): While GigaCloud reports significant growth in GMV, web traffic data for its B2B marketplace, GigaB2B, indicates low activity. At its peak, the site had only 1,000 visits

Latest Survey from Sotera Digital Reveals Shocking State of Mobile Phone Security in the Workplace.

February 5, 2024, New York - Sotera Digital Security, a leading US based provider of secure communications solutions, has today released its findings from a survey it conducted among over 1,000 senior personnel of large businesses and multinational corporations across the globe. Sectors covered by the survey participants focused on those that require the need for ultra-secure and private communications - both regionally and worldwide - with clients, colleagues and suppliers; namely legal, pharmaceutical, media and corporate affairs, government, and blockchain / AI tech specialists. The survey results provide key

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo Clinical trials, the linchpin of medical research, have long been riddled with inefficiencies, from patient recruitment bottlenecks to data management hurdles. As a technology and banking analyst, I've seen how digital solutions can overhaul entire sectors, offering improved productivity and streamlined processes. It's high time that clinical trials get a dose of such digital innovation, and there's a potent combination on the horizon: digital watermarking coupled with Artificial Intelligence (AI). At first glance, one might wonder: how can a technique often